Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Autologous Stem Cell Transplantation for Multiple Myeloma Patients Whose Myeloma Defining Event Was Slim

Iuliana Vaxman, Shaji Kumar, Inbar Cohen, Shai O. Shimony, Angela Dispenzieri, Francis Buadi, David Dingli, Martha Lacy, Eli Muchtar, Prashant Kapoor, William J. Hogan, Suzanne R Hayman, Nelson Leung, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma M Warsame, Morie A. Gertz

Blood (2024) 144 (Supplement 1): 7078.

https://doi.org/10.1182/blood-2024-205062

Published: 2024

Journal Articles

Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma

Blood (2024) 144 (Supplement 1): 83.

https://doi.org/10.1182/blood-2024-202098

Published: 2024

Journal Articles

Improved Survival with Daratumumab-Cybord Compared to Cybord As Frontline Therapy in Immunoglobulin Light Chain (AL) Amyloidosis

Blood (2024) 144 (Supplement 1): 2400.

https://doi.org/10.1182/blood-2024-209102

Published: 2024

Journal Articles

Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients with Relapsed or Refractory Multiple Myeloma, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms

N. Nora Bennani, Joselle Cook, Susan M. Geyer, Brenda F Ginos, Lianwen Zhang, Javier Munoz, Stephen Broski, Stephen Russell, Kah-Whye Peng, Martha Lacy

Blood (2023) 142 (Supplement 1): 5004.

https://doi.org/10.1182/blood-2023-190664

Published: 2023

Journal Articles

High Prevalence of Iron Deficiency Among Daratumumab-Treated Newly Diagnosed Multiple Myeloma Patients

Blood (2023) 142 (Supplement 1): 3337.

https://doi.org/10.1182/blood-2023-184607

Published: 2023

Journal Articles

Cumulative Deficits Frailty Index and Relationship Status Predict Survival in Patients with Multiple Myeloma

Nadine Abdallah, Paul DiZona, Amanika Kumar, Betsy LaPlant, Terri Menser, Sarah Aug, Megan Weivoda, Joselle Cook, Francis Buadi, Suzanne R. Hayman, Angela Dispenzieri, Martha Lacy, Morie A Gertz, S. Vincent Rajkumar, Shaji Kunnathu Kumar

Blood (2023) 142 (Supplement 1): 1986.

https://doi.org/10.1182/blood-2023-187845

Published: 2023

Journal Articles

Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma

Yuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, K. Martin Kortuem, Laura A. Bruins, Jessica E. Schmidt, Xiu-Bao Chang, Paul Langlais, Moulun Luo, Patrick Jedlowski, Betsy LaPlant, Kristina Laumann, Rafael Fonseca, P. Leif Bergsagel, Joseph Mikhael, Martha Lacy, Mia D. Champion, A. Keith Stewart

Blood (2014) 124 (4): 536–545.

https://doi.org/10.1182/blood-2014-02-557819

Published: 2014

Includes: Supplemental data

Journal Articles

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study

Blood (2014) 123 (12): 1826–1832.

https://doi.org/10.1182/blood-2013-11-538835

Published: 2014

Journal Articles

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

Anita D'Souza, Martha Lacy, Morie Gertz, Shaji Kumar, Francis Buadi, Suzanne Hayman, David Dingli, Steven Zeldenrust, Robert Kyle, Stephen Ansell, David Inwards, Patrick Johnston, Ivana Micallef, Luis Porrata, Mark Litzow, Dennis Gastineau, William Hogan, Angela Dispenzieri

Blood (2012) 120 (1): 56–62.

https://doi.org/10.1182/blood-2012-04-423178

Published: 2012

Journal Articles

Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma

Sumit Madan, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Morie Gertz, MD, Francis Buadi, MD, Suzanne R. Hayman, MD, Kristen Detweiler-Short, David Dingli, M.D., Ph.D., Steven Zeldenrust, MD, John Lust, MD, PhD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2010) 116 (21): 1964.

https://doi.org/10.1182/blood.V116.21.1964.1964

Published: 2010

Journal Articles

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Kristen Detweiler Short, RN, CNP, Joseph Mikhael, MD, Angela Dispenzieri, MD, Morie Gertz, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Martha Lacy, MD

Blood (2010) 116 (21): 1965.

https://doi.org/10.1182/blood.V116.21.1965.1965

Published: 2010

Journal Articles

Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score

Shaji Kumar, MD, Morie Gertz, MD, Martha Lacy, MD, David Dingli, MD, PhD, Suzanne R. Hayman, MD, Francis Buadi, MD, Kristen Detweiler-Short, Steven Zeldenrust, MD, Nelson Leung, MD, Philip R. Greipp, MD, John Lust, MD, PhD, Stephen Russell, MD, PhD, Robert Kyle, MD, Vincent Rajkumar, Angela Dispenzieri, MD

Blood (2010) 116 (21): 1892.

https://doi.org/10.1182/blood.V116.21.1892.1892

Published: 2010

Journal Articles

Higher Plasma Cell Burden Predicts for Early Death In Patients with AL Amyloidosis

Cheng E. Chee, MD, S. Vincent Rajkumar, MD, Morie Abraham A Gertz, MD, Martha Lacy, MD, Steven Zeldenrust, MD, Shaji Kumar, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, Stephen Russell, MD, PhD, Robert Kyle, MD, Philip R. Greipp, MD, Angela Dispenzieri, M.D.

Blood (2010) 116 (21): 1893.

https://doi.org/10.1182/blood.V116.21.1893.1893

Published: 2010

Journal Articles

Trend towards Improved Day 100 and 2-Year Survival After SCT for AL Amyloidosis: Outcomes Before and After 2006

Morie Abraham Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, M.D., Shaji Kumar, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Nelson Leung, MD, William J Hogan, MBBCh, Suzanne R. Hayman, MD

Blood (2010) 116 (21): 3554.

https://doi.org/10.1182/blood.V116.21.3554.3554

Published: 2010

Journal Articles

Acute Renal Failure Is a Common Presentation of Engraftment Syndrome In Light Chain Amyloidosis (AL) Patients After Autologous Stem Cell transplantation.

Maria V Irazabal, MD, Aflonso Eirin, MD, Morie Abraham A. Gertz, MD, Angela Dispenzieri, MD, Shaji Kumar, MD, Francis Buadi, MD, Martha Lacy, MD, Suzanne R. Hayman, MD, David Dingli, MD, PhD, William J Hogan, MBBCh, Nelson Leung, MD

Blood (2010) 116 (21): 3468.

https://doi.org/10.1182/blood.V116.21.3468.3468

Published: 2010

Journal Articles

Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization.

Morie Abraham Gertz, MD, Dennis Gastineau, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Shaji Kumar, MD, David Dingli, M.D., Ph.D., Nelson Leung, MD, Robert Wolf, PharmD, RPh, William J Hogan, MBBCh, Francis Buadi, MD

Blood (2010) 116 (21): 3469.

https://doi.org/10.1182/blood.V116.21.3469.3469

Published: 2010

Journal Articles

Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

Morie Abraham A. Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Shaji Kumar, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Stephen M. Ansell, MD, PhD, Dennis Gastineau, MD, David James Inwards, MD, Patrick B Johnston, MD, PhD, Mark R. Litzow, MD, Ivana Micallef, MD, Luis Porrata, MD, Nelson Leung, MD, Robert Wolf, PharmD, RPh, William J Hogan, MBBCh, Suzanne R. Hayman, MD

Blood (2010) 116 (21): 3557.

https://doi.org/10.1182/blood.V116.21.3557.3557

Published: 2010

Journal Articles

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Nelson Leung, MD, Shaji Kumar, MD, Angela Dispenzieri, M.D., Martha Lacy, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Dennis Gastineau, MD, Morie Gertz, MD

Blood (2010) 116 (21): 3572.

https://doi.org/10.1182/blood.V116.21.3572.3572

Published: 2010

Journal Articles

Unraveling Early Mortality In Patients with AL Amyloidosis

Cheng E. Chee, MD, Vincent Rajkumar, PhD, Morie Gertz, Martha Lacy, MD, Steven Zeldenrust, Shaji Kumar, MD, Suzanne R. Hayman, MD, Francis Buadi, MB, CHB, Stephen Russell, MD, PhD, Robert Kyle, MD, Philip R. Greipp, MD, Angela Dispenzieri, M.D.

Blood (2010) 116 (21): 4990.

https://doi.org/10.1182/blood.V116.21.4990.4990

Published: 2010

Journal Articles

Pre-Stem Cell Transplant Induction Therapy Does Not Affect Post-Transplant Survival In Light Chain (AL) Amyloidosis

Sumit Madan, MD, Shaji Kumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Francis Buadi, MD, Suzanne R. Hayman, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Morie Gertz, MD

Blood (2010) 116 (21): 370.

https://doi.org/10.1182/blood.V116.21.370.370

Published: 2010

NARROW

Autologous Stem Cell Transplantation for Multiple Myeloma Patients Whose Myeloma Defining Event Was Slim

Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma

Improved Survival with Daratumumab-Cybord Compared to Cybord As Frontline Therapy in Immunoglobulin Light Chain (AL) Amyloidosis

Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients with Relapsed or Refractory Multiple Myeloma, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms

High Prevalence of Iron Deficiency Among Daratumumab-Treated Newly Diagnosed Multiple Myeloma Patients

Cumulative Deficits Frailty Index and Relationship Status Predict Survival in Patients with Multiple Myeloma

Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score

Higher Plasma Cell Burden Predicts for Early Death In Patients with AL Amyloidosis

Trend towards Improved Day 100 and 2-Year Survival After SCT for AL Amyloidosis: Outcomes Before and After 2006

Acute Renal Failure Is a Common Presentation of Engraftment Syndrome In Light Chain Amyloidosis (AL) Patients After Autologous Stem Cell transplantation.

Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization.

Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Unraveling Early Mortality In Patients with AL Amyloidosis

Pre-Stem Cell Transplant Induction Therapy Does Not Affect Post-Transplant Survival In Light Chain (AL) Amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only